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Cytogenetic and FISH analyses of pancreatic carcinoma
reveal breaks in 18q1 I with consistent loss of
18q12-qter and frequent gain of 18p
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Summary Chromosome 18 was analysed using a banding technique and fluorescence in situ hybridization (FISH) in 13 pancreatic
carcinoma samples. The cytogenetic analysis revealed that chromosome 18 abnormalities were present in all cases and that several different
rearrangements, such as translocations, deletions, dicentrics and ring chromosomes, were often found together. FISH mapping using 18q
YAC probes showed that all tumours had lost at least one copy of 18q and that 18p was over-represented in 6 of the 13 cases. Furthermore,
out of 13 identified deletion breakpoints on 18q, 11 were mapped to 18q11. The clustering of breaks close to the centromere indicates that
loss of genes in bands 18q11 and 18q12, in addition to those located in 18q21, e.g. DPC4 and DCC, are important in the development of
pancreatic tumours.
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Although only a handful oflarger series ofcytogenetically investi-
gated pancreatic carcinomas have been reported, several frequent
recurrent chromosomal imbalances, such as trisomy 7 and 20,
monosomy 18, loss of Ip, 3p, 6q, 8p, 9p, 17p and 19p, and gain of
lq, 3q, 8q, 1 lq, 19q and 20q, have been identified (Johansson et al,
1992; Bardi et al, 1993; Griffin et al, 1994, 1995; Gorunova et al,
1998). The pattern ofcytogenetic imbalances seems characteristic
for pancreatic cancer, albeit many of the individual changes are
also found in other solid tumours (Mertens et al, 1997). Loss of
heterozygosity (LOH) studies have confirmed the cytogenetic
features in pancreatic tumours as regards losses, showing a high
incidence of allelic imbalance at lp, 3p, 9p, 13q, 17p and 18q
(Seymour et al, 1994; Hahn et al, 1995; Shridhar et al, 1996). In
some ofthe frequently deleted regions, a concomitant inactivation
of a tumour-suppressor gene (TSG) on the remaining normal
chromosome has been shown, i.e. CDKN2A in 9p2l (Caldas et al,
1994; Bartsch et al, 1995), BRCA2 in 13q12 (Goggins et al, 1996),
TP53 in 17pl3 (Ruggeri et al, 1992; Scarpa et al, 1993) and
SMAD4 (DPC4) in 18q21 (Hahn et al, 1996), whereas the TSGs in
the other loci remain to be identified.
The most common chromosome aberration in pancreatic cancer
is monosomy 18 (Johansson et al, 1992; Bardi et al, 1993; Griffin
et al, 1994, 1995). However, recent cytogenetic (Gorunova et al,
1998) and comparative genomic hybridization (CGH) analyses
(Mahlamaki et al, 1997) have also revealed frequent partial dele-
tions of 18q. In the majority of the cases, the CGH data indicate
breaks in 18cen-q21, leading to loss of the distal half of 18q
(Mahlamaki et al, 1997), including the genes DCC and SMAD4
(Fearon et al, 1990; Hahn et al, 1996). As a large proportion of
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these breaks are located close to the centromere, in bands 18q11-12
(Gorunova et al, 1998), at quite a distance from DCC and SMAD4,
larger deletions of 18q, including other putative TSGs, may be
pathogenetically important in pancreatic carcinoma. However,
cytogenetic and CGH breakpoint mapping of chromosome 18 is
particularly difficult and may hence yield uncertain information. To
investigate further such changes in pancreatic carcinoma and to
map the extension of the 18q deletions with higher precision, we
have applied fluorescence in situ hybridization (FISH), using a
whole chromosome 18 paint (wcp) probe, a partial paint probe
(pcp) for 18q and precisely mapped YAC clones.
MATERIALS AND METHODS
Patients
Thirteen tumour specimens were obtained from 12 patients with
exocrine carcinoma of the pancreas, including one located in
papilla Vateri, undergoing treatment at the Department of Surgery,
Lund University Hospital, Sweden. For carcinomas unresectable
at the time of diagnosis, i.e. when pancreatectomies could not be
performed, the site of origin was based on pre- and perioperative
examinations. Clinical data, including sex, age, morphology, grade
and site, are given in Table 1.
Cytogenetic analysis
The initial cytogenetic analyses, using G-banding, were performed
on short-term, non-passaged cultures, as described in Gorunovaet al
(1995). The cultures were passaged fourtoeight times forexpansion
and to free them from normal cells. Metaphase spreads for FISH
analysis (see below) were then obtained. To exclude the possibility
that the FISH studies were made on chromosomal rearrangements
arising in vitro, all chromosome 18 abnormalities identified by FISH
were compared with the initial karyotypes and only those seen in
non-passaged cultures were considered in the FISH results.
18931894 M Hoglund etal
Table 1 Clinical, cytogenetic and FISH data on the 12 patients with pancreatic cancer
Patient noJ Sex/ Morphologyb Gradec Sited Mode Cytogenetic abnormalities Imbalances identified by FISH
lab. codea age of chromosome 18
(years)
1/129-94 (LPC1p) M/68 Inc - Caput 3 add(18)(q12) x 2, del(18)(q21) x 2 - 18q11l-qter, + 18pter-cen-18q11
2/1298-94 (LPC2p) M/49 D PD-WD Caput 3 - 18 - 18
3/1330-94 (LPC3p) F/53 lpmc WD Capute 3 der(18)t(18;21)(q11;q11) x 2 - 18q11l-qter, + 18pter-cen-qll
4/1619-94 (LPC4p) M/75 C PD PV 3 - 18, add(18)(qll) x 1-2 -18q x 2
5/1674-94 (LPC5m) F/66 C PD NOS 3 der(18)t(18;22)(q12;q11) - 18q12-qter
6/2468-94 (LPC6p) M/52 D MD Caput 3 - 18, del(18)(pll), - 18q11l-qter, - 18pter-cen-qll x 2,
der(22)t(18;22)(q1l ;p13)ins(22;?)(p13;?) - 18cen-ql11
7/3273-94 (LPC7m) F/73 C PD NOS 2 - 18 - 18
8/244-95 (LPC8p) F/77 C PD NOS 3 add(18)(q12) x 2 - 18q x 2, + 18p x 2
9/940-95 (LPC9p) F/64 C PD Caput 3 i(18)(pl0) or del(18)(q12), - 18q11l-qter x 2
add(18)(qll)
10/2090-95 (LPC1Om) F/61 C MD NOS 3 - 18, idic(18)(qll) - 18q11l-qter x 2, + 18p x 2
11/3462-95 (LPC11p) M/48 C PD Corpus 4 add(18)(q12) x 3-4 - 18q12-qter x 2, + 18pter-cen-ql12 x 2,
+ 18pter-cen-qll
/3463-95 (LPC11m) M/48 C PD Corpus 4 add(18)(q12) x 3-4 - 18q122-qterx 2, +18pter-cen-q12
12/1077-96 (LPC12m) M/55 C MD NOS 3 -18, dic(18;21)(q11;p11) -18, -18q11l-qter
aName of low-passage cell line in brackets: p, primary tumour sample; m, abdominal metastatic sample. bInc, inconclusive (only cells with atypia in biopsy
material; final diagnosis of pancreatic cancer was based on perioperative findings); D, ductal cancer; Ipmc, intraductal papillary mucinous carcinoma; C,
carcinoma. cPD, poorly differentiated; WD, well differentiated; MD, moderately differentiated. dPV, papilla Vateri; NOS, pancreas not otherwise specified.
eMulticentric origin from pancreas, papilla Vateri and choledochus.
Probes and FISH analysis
The labelled wcpl8 probe was purchased from Cambio
(Cambridge, UK). The pcpl8q was obtained from CP Li
Biomedical Research (Arlington, USA). The following chromo-
some 18 YACs, obtained from CEPH, were used: 694b3, 820c6,
766f9, 937hl2, 739a3 (SMAD2), 745bll (SMAD4), 955c2 and
961hl2. The YAC 4ODH1, spanning the DCC locus, was kindly
provided by Dr G Silverman. The approximate chromosomal loca-
tion ofthe YAC markers is given in Figure 2. The YAC map given
on the right side ofthe ideogram is based on the map published by
Giacalone et al (1996), except for 955c2 (Bray-Ward et al, 1996).
YAC probe preparations were performed as in Lengauer et al
(1992), using Alu primers described in Hoglund et al (1998).
Probes were labelled with either biotin or digoxygenin-conjugated
dUTP, using Amersham's Mega Prime kit (Amersham, UK). After
labelling, the DNA was purified on a Sepharose CL-6B column
(Pharmacia, Uppsala, Sweden). The FISH analyses were
performed essentially as described in Hoglund et al (1998). The
hybridization signals were analysed in a CytoVision Ultra system
(Applied Imaging, Sunderland, UK), using a charged coupled
device (CCD) camera. After an initial screen of 20-30
metaphases, 10-20 per probe were analysed in detail.
RESULTS
The cytogenetic and FISH results regarding chromosome 18 are
summarized in Table 1 and Figures 1-3.
LPC1p
The cytogenetic analysis showed the presence of two add(18)(ql2)
and two del(18)(q21). The add(18) was negative for the most prox-
imal marker on the q arm, but positive for the pcpl8q, indicating a
break in 18q1 1. The del(l8) was found to have a break between
the 739a3 and the 745b1 1 YAC probes, corroborating the 18q21
breakpoint. In addition, the FISH analysis disclosed two derivative
chromosomes containing the 745bl1-955c2 YACs, and these
derivatives were later cytogenetically reinterpreted as der(7)t(7;18)
(qll ;q21). As this tumour was triploid, one copy of 18qI1-qter was
lost, whereas one copy of 18pter-cen-18q11 was gained.
LPC2p
The cytogenetic investigation of this triploid tumour revealed the
presence of two normal chromosomes 18. The wcpl8 probe also
detected one ring chromosome. The ring contained one segment of
18q origin, as determined by the pcpl8q. This ring chromosome
had cytogenetically been interpreted as a der(6)r(6)(p25q21)ins
(6;?)(ql3;?). A proportion ofthe cells did not contain the ring but
a large chromosome, ins(6;?)(ql3;?), with two to three segments
of 18q origin. None of the 18q21 probes hybridized to these
segments. Hence, one copy ofchromosome 18 was lost except for
the short unidentified 18q regions present in the ring and ins(6;?)
chromosomes.
LPC3p
The cytogenetic analysis revealed two copies of a
der(18)t(18;21)(qll;qll) and two normal chromosomes 18. The
breakpoint in the der(18) was assigned to 18qll by FISH. This
triploid tumour had thus lost one copy of 18qll-qter and gained
one copy of 18pter-cen-ql 1.
LPC4p
The cytogenetic analysis disclosed one to two add(18)(qll) in
addition to one normal chromosome 18. The add(18) was positive
for both the 18p YACs but negative for all the 18q1 1-22 probes as
well as for the pcpl8q, indicating a break within, or very close to,
the centromere. The break was therefore assigned to 18q1l.1. As
this tumour was triploid, two copies of 18q had been lost.
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Figure 1 Partial karyotypes showing the chromosome 18 aberrations. Normal chromosomes 18 are placed to the left, when present. Cytogenetically and/or by
FISH identified material (other than chromosome 18), and breakpoints are indicated by corresponding chromosome numbers and arrowheads. Detailed
description of the aberrations is given in the Results. For cases 2 and 6, arrows are used to show approximate locations of breaks
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Figure 2 Summary of the FISH results. To the left, an ideogram of chromosome 18 showing the approximate locations of the YAC markers used. Open circle
with thick line, probe absent; filled circle, probe present; shaded circle, presence of probe inferred from cytogenetic and/orwcpl8 and pcpl8q data; circle with
thin line, probe not tested; filled box, signal with pcpl8q (cen-766f9); open box, no signal with pcpl8q. Ideograms on top show the schematic appearance of
chromosomes with chromosome 18 material. Regions of 18q origin, red shaded; regions of 18p origin, yellow shaded; regions of unidentified origin, grey
shaded
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Figure 3 Summary of imbalances and breakpoints identified by FISH. To the left, an ideogram of chromosome 18 showing the approximate locations of the
YAC markers used. Chromosomal breaks in the q arm leading to deletions are indicated with arrowheads. Lines denote the presence of the indicated segment.
The small unidentified segments of 18q origin detected in LPC2p, LPC6p and LPC12m are not included
LPC6p
Cytogenetically, this tumour displayed two normal chromosomes The cytogenetic investigation of this triploid tumour revealed a
18 and a der(18)t(18;22)(ql2;qll). The breakpoint in the latter del(18)(pl1) and a der(22)t(18;22)(qll;p13)ins(22;?)(p13;?). The
was mapped to the interval between 766f9 and 937h 12. Hence, FISH analysis, however, showed that the del( l8)(p I1) had a break
this triploid tumour had lost one copy of 18q12-qter. in 18q 1 1 rather than in the p arm and that the del(18) was identical
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18p YACs hybridized to both arms of the add(l8), indicating the
presence of a possible isochromosome of 18p. The cytogenetic
reanalysis, however, showed that the arms were not symmetrical,
suggesting that the add( 18) was in fact a der( 1 8)t(18;18)(pl1 ;q11).
As this tumour was triploid, two copies of 18q were lost and two
copies of 18p were gained.
LPC9p
The cytogenetic analysis showed, in addition to one normal chro-
mosome 18, an i(18)(plO), alternatively a del(18)(q12), and an
add(l8)(q 1). The FISH analysis, using wcpl8, all 18q YACs and
the pcp18q, revealed one normal chromosome 18 and two different
add(18)(qll). Thus, two copies of 18qll-qter were lost in this
triploid tumour.
Figure 4 (A) FISH result from simultaneous hybridization with the wcpl8
(yellow-white) and pcpl 8q specific (red) probes to a LPC6p metaphase. The
wcp18 signal overlapping with the pcpl8q signal was removed from the
figure for clarity. (B) FISH result from hybridization with YAC 694b3 to a
LPC1Om metaphase
to the der(22) as regards the presence of 18q material. Two other
chromosomes were shown to contain chromosome 18 material
using FISH. One of these (ml, Figures 2 and 4A) had one inter-
stitial and one terminal segment of 18p origin. The interstitial
segment was positive for both the 18p YACs, whereas the terminal
segment was negative for both these probes. The second chromo-
some, cytogenetically identified as der(11)t(11;11)(p14;q13),
contained one interstitial segment of 18q that was negative for the
18q21 YACs. Thus, this tumour had lost one copy of 18q1 l-qter,
two copies of 18pter-cen-q11 and one copy of 18cen-q11.
LPC1Om
The cytogenetic analysis revealed an idic(18)(q11) and one normal
chromosome 18. The FISH analysis also identified one metacen-
tric and one smaller marker with chromosome 18 material (Figure
4B). The metacentric marker had 18p material on one ofthe arms,
positive for both 18p YACs. The smaller marker was positive for
the 18p YACs and had a break in the centromere, or very close to
it. The idic(18) chromosome arms hybridized to the wcp18,
whereas the central segment was positive for pcpl8q. Further
hybridizations with the 18p YACs verified the idic(18). The
central segment was negative for YAC 766f9, the most proximal
marker on the q arm. Thus, this triploid tumour had lost two copies
of 18qI1 -qter and gained two copies of 18p.
LPC11p and LPC11 m
The cytogenetic analysis ofboth the primary tumour and its metas-
tasis revealed three to four copies of add(18)(ql2). The FISH
analysis, however, disclosed a second derivative 18, in two copies,
with a large insertion in 18p, and YAC hybridizations showed that
the insertion point was between 694b3 and the telomere.
Cytogenetically, this insertion was identified as an
ins(l8;X)(pll;q21q28). One more derivative, der(l8), was posi-
tive for pcp18q and the two 18p YACs but negative for 766f9. The
add(18)(ql2) was positive for the 766f9 and 937h12 probes but
negative for the 18q21-22 markers. In the LPC1lp, the
add(l8)(q12), ins(18;X) and der(l8) were present in four, two and
one copy respectively. The two former abnormalities were found
in three and two copies in LPC11 m, whereas the der(18) was only
seen occasionally in the metastasis. As both LPC11p and LPC11m
were tetraploid, the former had lost two copies of 18q12-qter and
gained two copies of 18pter-cen-q12 and one copy of
18pter-cen-q 11, whereas the latter sample had lost two copies of
18q12-qter and gained one copy of 18pter-cen-q12.
LPC7m
Only one copy of chromosome 18 was present, as shown by both
cytogenetics and FISH. Thus, one chromosome 18 was lost in this
diploid tumour.
LPC8p
By cytogenetic means two add(18)(q12) and one normal chromo-
some 18 were detected. The FISH analysis revealed that the
LPC12m
The cytogenetic analysis showed one dic(l8;21)(q1l;p12) and one
normal chromosome 18. The FISH analysis also disclosed two
markers with small segments of 18q material, identified only with
the pcp1 8q. The dic(18;21) was negative for the 766f9 probe but
positive for pcpl8q, indicating a break in 18q11. On balance, this
triploid tumour had lost one chromosome 18 and one copy of
18ql l-qter.
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In summary, the combined cytogenetic and FISH results revealed
loss of 18q material, consistently including 18ql2-qter, in all
tumours. Out of 13 identified breaks resulting in deletion of 18q,
11 occurred in 18q11. Over-representation of 18p was detected in
six samples, always including the entire arm.
DISCUSSION
The present results showing gain of 18p in almost half of the
pancreatic carcinoma samples analysed (6 out of 13) agree well
with the previous CGH studies of Solinas-Toldo et al (1996),
Fukushige et al (1997) and Mahlamaki et al (1997), revealing 18p
over-representation in 4 of 23, 8 of 18 and 5 of 18 informative
cases respectively. Neither in the present series nor in the previous
CGH studies were partial duplications of 18p seen, i.e. no specific
l8p region can, as yet, be delineated as the target for the detected
over-representation. Gains of 18p have also been described in tran-
sitional cell carcinoma ofthe bladder, with a distinct amplification
of 18pl1 (Voorter et al, 1995). The oncogene YES, a SRC-related
membrane-bound tyrosine kinase, is located within this band
(Silverman et al, 1993) and has been found to be overexpressed in
both melanoma (Loganzo et al, 1993) and colon carcinoma (Park
et al, 1993). It is possible that over-representation of 18p may
increase the expression of genes on this arm, such as YES, of
possible pathogenic importance in pancreatic carcinogenesis. In
four of the present cases (LPC2p, LPC6p, LPC7m and LPC12m),
18p material was lost. In three ofthese, however, the 18p deletions
occurred through loss ofone entire chromosome 18, and it is likely
that the concomitant 18q deletion was the pathogenetically impor-
tant change in these cases.
All 13 samples investigated showed under-representation of 18q
material - as loss of chromosome 18 in three cases, complete loss
of 18q in three cases and partial deletions of 18q in seven cases.
None of the tumours displayed a total absence of a tested YAC
marker, i.e. nullisomy for 18q material was not seen. The observed
frequent loss of 18q is in agreement with earlier cytogenetic
(Johansson et al, 1992; Bardi et al, 1993; Griffin et al, 1994, 1995),
CGH (Fukushige et al, 1997; Mahlamaki et al, 1997) and LOH
studies (Hahn et al, 1995). In the ten cases in which losses of 18q
occurred through breaks in the q arm, the breakpoints were local-
ized using both YAC and pcpl8q probes. Of the recorded 13
breaks in 18q, 11 were mapped to 18q11. The fact that the break-
points clustered to at least two different subregions within this
band, 18q11.1 and 18q11.2 (Figure 3), argues against the presence
ofa preferentially break-prone region induced by a local change in
the chromatin, as has been suggested for the frequent breaks in
3pl4 in pancreatic carcinoma (Shridhar et al, 1996). Furthermore,
the clustering of breaks close to the centromere indicates that loss
of genes in bands 18q11 and 18q12 are important in the develop-
ment ofpancreatic tumours.
SMAD4 and DCC are located in 18q21 and both these genes
have been implicated in pancreatic tumorigenesis (Hohne et al,
1992; Simon et al, 1994; Hahn et al, 1996). However, no inacti-
vating mutations in DCC have been reported in pancreatic cancer,
and the importance of this gene in neoplasia has recently been
questioned (Fazeli et al, 1997). SMAD4, on the other hand, has
been shown to be functionally inactivated in a large proportion of
pancreatic carcinomas (Hahn et al, 1996). However, SMAD4 is
only mutated in 22% of the cases showing LOH at this locus
(Hahn et al, 1996), indicating that this gene may not always be the
target for 18q deletions. The closely linked SMAD2, which shows
a great sequence similarity to SMAD4 and also functions as part of
the transforming growth factor beta (TGFB) signal transducing
pathway (Eppert et al, 1996), may, in analogy with SMAD4, func-
tion as a tumour-suppressor gene, although no SMAD2 mutations
in pancreatic carcinomas have been reported as yet. Taking into
account the high frequency, 90-100%, of 18q deletions reported in
pancreatic tumours (Hahn et al, 1995; Gorunova et al, 1998; this
report), the relatively low incidence of functional abrogation of
SMAD4 in cases with LOH at this locus, and the present identifi-
cation ofproximal 18q deletion breakpoints, it seems reasonable to
suggest the presence ofan additional TSG on 18q ofimportance in
pancreatic carcinomas. In favour of yet another TSG on 18q are
recent molecular genetic findings in colon and lung carcinomas.
Colon cancers show a similar deletion profile of 18q, with frequent
breaks in 18qll-12, as pancreatic carcinoma, but with few
concomitant inactivating mutations of SMAD4 or SMAD2
(Thiagalingam et al, 1996). Similarly, in lung cancer, which shows
LOH at 18q21 in 30-60% (Schutte et al, 1996), functional loss of
SMAD4 or SMAD2 is very rare (Nagatake et al, 1996; Uchida et al,
1996). Furthermore, mutations of SMAD4 and SMAD2 are rarely
seen in other tumours, such as carcinomas of the oesophagus,
stomach, bladder, prostate and breast showing LOH at 18q21
(Barrett et al, 1996; Lei et al, 1996; Schutte et al, 1996). We thus
conclude that 18q harbours at least one more proximally located
TSG, which is shared among various tumour types, including
pancreatic tumours, with 18q deletions, and one, SMAD4, that may
be specific for pancreatic cancer.
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